Adeniyi Aderoba

and 6 more

Objective To investigate perinatal mortality, morbidity and obstetric intervention after introducing universal third-trimester ultrasound scan for growth restriction. Design Prospective cohort study Setting Oxfordshire (OUH), UK Population Women with a non-anomalous singleton pregnancy undergoing pregnancy care and term delivery at OUH with an estimated-date-of-birth between 01/Jan/2014 and 30/Sept/2019. Methods Universal ultrasound for fetal growth restriction between 35+0 and 36+6 weeks was introduced in 2016. The outcomes of the next 18631 eligible term pregnancies were compared, using logistic regression, with the previous 18636 who had clinically-indicated ultrasounds only. ‘Screen positives’ for growth restriction were managed according to a pre-determined protocol. Main Outcome Measures Extended perinatal mortality, a composite of mortality or encephalopathy Grade II-III, and expedited birth. Other outcomes included composite adverse outcomes used elsewhere, detection of birthweight (<10th centile) and birth <39+0 weeks. Results Extended perinatal deaths decreased from 1.7/1000 to 1.2/1000 births (aOR: 0.73; 0.43 -1.25); mortality or severe morbidity decreased from 2.9/1000 to 1.9/1000 births (OR: 0.67; 0.44-1.03). Expedited births increased from 35.2% to 37.7% (OR: 1.08; 1.04 – 1.14). Birth prior to 39+0 weeks fell 10.5% (OR 0.89: 0.85 – 0.94). Birthweight (<10th centile) detection using fetal biometry alone was 31.4%, and rose to 40.5% if all abnormal scan parameters were used. Conclusion Introducing a universal ultrasound for growth restriction has limited impact on mortality and severe morbidity, but only small increases in intervention, and less early-term birth, are possible. The detection of birthweight (<10th c) improved where markers of growth restriction are used.
DEATH AND SEVERE MORBIDITY IN ISOLATED PERIVIABLE SMALL-FOR-GESTATIONAL-AGE FETUSESBy Meler et alDescriptive title:Middle cerebral artery Doppler improves risk stratification of SGA babies at a peri-viable gestationMini-commentary by Lawrence ImpeySmall for gestational age (SGA) babies identified before 26 weeks are a heterogenous group but the largest contributor is ‘isolated’ SGA’. Most are ‘constitutionally’ small, but placental issues are common. Traditionally, the ultrasound Doppler parameters used to identify the most at risk are the umbilical artery (UA) and uterine artery (UtA). This paper (Meler et al, BJOG, 2022) challenges the dogma that MCA Doppler in early onset-SGA babies is of limited use, reporting an 87% detection rate for a 14% false positive rate for UA and MCA together in predicting a severe composite adverse outcome (CAO).The analysis uses Doppler findings at referral, thereby reducing but not eliminating the ‘intervention paradox’, common to many analyses, whereby an ‘abnormal’ finding’s association with an outcome is altered because it leads to intervention.The group is defined by local centiles and only comprises those referred but, by including both apparently FGR and SGA babies, is less subject to selection bias. Because of the high risk nature and size of this cohort, the frequency of adverse outcomes is adequate for analysis of a severe CAO (20.4%), of death (15.4%) or long term morbidity that is sufficiently serious and includes postnatal follow up (minimum 9 months).The role of MCA Doppler with placental failure is poorly understood. Near term, as part of the cerebroplacental ratio (CPR), it helps identify the at-risk SGA baby (Veglia et al, UOG, 2018), and even some at-risk normally grown babies. Earlier, however, the role of UA Doppler is clear (Alfirevic et al, Cochrane, 2017). That MCA Doppler adds predictive value at diagnosis is important because it will allow enable more appropriate counselling, follow up and potentially better timing of iatrogenic birth.What does the analysis make of UtA Doppler and the ductus venosus (DV)? It is surprising (Allen et al, UOG 2016) that the former was not predictive, but as its role is well established, this could be the subject of intervention bias. Mild abnormalities (PI>95th c) of the DV were not useful, but severe ones, occurring late in the deterioration in FGR, will still be useful to time iatrogenic birth (Lees et al, Lancet, 2015).MCA Doppler in referred small peri-viable babies improves risk stratification, a process central to maternity care. The ‘checklist’ approach to risk must be replaced by models using continuous variables (as opposed to cut offs of ‘abnormal’) of multiple independent risk factors: as with aneuploidy screening. Only then can we better identify high risk (sensitivity) whilst not over-medicalising pregnancy (specificity). Developing this is complex, not least because of the rarity and gestation-dependence of serious perinatal events and because of the presence of the intervention paradox in large datasets. Nevertheless, the Tommy’s app (https://www.tommys.org/) is a welcome start. Such screening is likely to need to be staged, and this analysis demonstrates one risk factor potentially worth including following a 20 week scan.

Angelo Cavallaro

and 5 more

OBJECTIVE Assess whether antenatal corticosteroids for fetal lung maturation are associated with hypoglycaemia in neonates born at term. DESIGN Cohort study of term singleton deliveries over a 3-year period. SETTING Tertiary UK hospital. POPULATION The cohort includes neonates not exposed to corticosteroids; those exposed before 34 weeks because of suspected preterm birth but delivered at term (group 1); those exposed after 34 weeks because of anticipated late preterm birth (group 2); and - included in the latter - a subgroup of neonates exposed within 7 days of their actual delivery (group 2a). METHODS Retrospective analysis of the association between exposure and neonatal outcomes using multivariate regression to adjust for confounders. MAIN OUTCOME MEASURES Severe neonatal hypoglycaemia requiring admission to NNU; and need for ventilatory support. RESULTS Amongst 20102 eligible pregnancies, 143 women received corticosteroids before 34 weeks; and 187 after 34 weeks, of which 106 were within 7 days of delivery. Severe hypoglycaemia occurred in 227 neonates. Univariate predictors of hypoglycaemia were maternal BMI, nulliparity, hypertension, diabetes, gestation at birth, birthweight<10 centile and corticosteroid exposure. Following adjustment for covariates, corticosteroid exposure was independently associated with hypoglycaemia in all exposed groups: group 1 adjusted odds ratio (aOR) 3.26 (1.38-7.73); group 2 aOR 4.56 (2.47-8.42); and group 2a aOR 5.70 (2.49-13.03). Ventilatory support was not significantly different in any of the exposed groups. CONCLUSION There is increased risk of hypoglycaemia in neonates exposed to antenatal corticosteroids who are born at term. The risk of hypoglycaemia is higher with decreasing corticosteroid-to-birth interval.

Samuel Dockree

and 5 more

Objective To define a trimester-specific reference interval for C-reactive protein (CRP) in healthy pregnant women, and to evaluate its accuracy for diagnosing infection. Design Retrospective cross-sectional and diagnostic accuracy study. Setting Tertiary hospital in Oxford, UK. Population Development cohort: 315 pregnant women from the Oxford Pregnancy Biobank with uncomplicated pregnancies, with longitudinal sampling in each trimester. Evaluation cohort: 50 pregnant women with suspected chorioamnionitis. Methods and main outcome measures We calculated a 95% reference interval for CRP in each trimester and evaluated its diagnostic accuracy for infection compared to that from current guidance (≤7 mg/L). Results Of the 315 healthy pregnant women in our study, concentrations of CRP were substantially higher than those in most non-pregnant populations. The reference intervals in each trimester were similar, with an upper reference limit of 18 mg/L. CRP increased log-linearly with body mass index in all trimesters (p<0.001). The sensitivity and specificity of CRP for diagnosing chorioamnionitis were 80% and 86%, respectively. The overall diagnostic accuracy using the pregnancy-specific reference interval was significantly greater than that of the existing standard (p=0.002). Conclusions A pregnancy-specific reference interval for CRP should be used to optimise diagnostic accuracy for infection in pregnant women. Chorioamnionitis was used as example of a localised infection with well-defined outcomes, but pregnancy-specific upper reference limits for CRP should be considered in any clinical setting including pregnant women.